Gisela Paulsen
2022 - Oncocyte Corp
In 2022, Gisela Paulsen earned a total compensation of $1.3M as Former President and Chief Operating Officer at Oncocyte Corp.
Compensation breakdown
| Option Awards | $233,738 |
|---|---|
| Salary | $356,426 |
| Stock Awards | $509,250 |
| Other | $241,712 |
| Total | $1,341,125 |
Paulsen received $509.3K in stock awards, accounting for 38% of the total pay in 2022.
Paulsen also received $233.7K in option awards, $356.4K in salary and $241.7K in other compensation.
Rankings
In 2022, Gisela Paulsen's compensation ranked 2,458th out of 5,683 executives tracked by ExecPay. In other words, Paulsen earned more than 56.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,458 out of 5,683 | 57th |
Division Manufacturing | 1,346 out of 3,091 | 57th |
Major group Chemicals And Allied Products | 607 out of 1,406 | 57th |
Industry group Drugs | 561 out of 1,307 | 57th |
Industry In Vitro and In Vivo Diagnostic Substances | 8 out of 29 | 72nd |
Source: SEC filing on May 19, 2023.
Paulsen's colleagues
We found five more compensation records of executives who worked with Gisela Paulsen at Oncocyte Corp in 2022.
2022
Ronald Andrews
Oncocyte Corp
Chief Executive Officer
2022
Douglas Ross
Oncocyte Corp
Chief Scientific Officer
2022
Anish John
Oncocyte Corp
Chief Financial Officer
2022
Joshua Riggs
Oncocyte Corp
Chief Executive Officer
2022
James Liu
Oncocyte Corp